Cargando…

589. Assessment of an Antiretroviral Therapy Policy in Patients with Human Immunodeficiency Virus at a Large Academic Medical Center

BACKGROUND: Accurate medication reconciliation upon hospital admission is crucial for patients with human immunodeficiency virus (HIV) to ensure continuation of appropriate antiretroviral therapy (ART). An ART policy was implemented at our institution which restricted ART ordering to infectious dise...

Descripción completa

Detalles Bibliográficos
Autores principales: Barber, Elizabeth, Phe, Kady, Russo, Hannah Palmer, Mohajer, Mayar Al
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253919/
http://dx.doi.org/10.1093/ofid/ofy210.596
_version_ 1783373604959813632
author Barber, Elizabeth
Phe, Kady
Russo, Hannah Palmer
Mohajer, Mayar Al
author_facet Barber, Elizabeth
Phe, Kady
Russo, Hannah Palmer
Mohajer, Mayar Al
author_sort Barber, Elizabeth
collection PubMed
description BACKGROUND: Accurate medication reconciliation upon hospital admission is crucial for patients with human immunodeficiency virus (HIV) to ensure continuation of appropriate antiretroviral therapy (ART). An ART policy was implemented at our institution which restricted ART ordering to infectious diseases physicians to increase appropriate ART prescribing following admission. The purpose of this study was to evaluate the effectiveness of the HIV medication restriction policy on the appropriateness of ART re-ordering upon admission. METHODS: This was a single-center, retrospective chart review conducted from July 2014 to June 2017 as a pre–post intervention study. The pre-intervention group included adult patients with HIV who received one or more doses of ART prior to implementation of the HIV medication restriction policy. The post-intervention group included adult patients with HIV who received one or more doses of ART after implementation of the policy. Exclusion criteria included patients who received ART for hepatitis B infection or prophylaxis, HIV post-exposure prophylaxis, or patients receiving a first dose of ART for occupational exposure. Home ART medication regimen and inpatient ART medication regimen were evaluated. The primary endpoint was to compare the rate of appropriate medication reconciliations completed before and after implementation of the HIV medication restriction policy. The secondary endpoint was to compare the time to restart of ART following admission. RESULTS: A total of 115 patients were included in this study. Appropriate medication reconciliation increased from 76% to 100% after implementation of the policy (P = 0.014). However, the mean time to re-initiation of ART increased from 7.9 hours to 14.5 hours after implementation of the policy (P = 0.01). ART regimens were restarted within 24 hours of admission in 96.7% of the pre-HIV policy group vs. 84% in the post-HIV policy group (P = 0.02). CONCLUSION: The mean time to re-initiation of ART increased after implementation of the HIV policy. However, restriction of ART ordering to infectious diseases physicians significantly increased the rate of appropriate medication reconciliation for patients with HIV. In light of these results, a procedure will be established to ensure the timely re-initiation of ART. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6253919
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-62539192018-11-28 589. Assessment of an Antiretroviral Therapy Policy in Patients with Human Immunodeficiency Virus at a Large Academic Medical Center Barber, Elizabeth Phe, Kady Russo, Hannah Palmer Mohajer, Mayar Al Open Forum Infect Dis Abstracts BACKGROUND: Accurate medication reconciliation upon hospital admission is crucial for patients with human immunodeficiency virus (HIV) to ensure continuation of appropriate antiretroviral therapy (ART). An ART policy was implemented at our institution which restricted ART ordering to infectious diseases physicians to increase appropriate ART prescribing following admission. The purpose of this study was to evaluate the effectiveness of the HIV medication restriction policy on the appropriateness of ART re-ordering upon admission. METHODS: This was a single-center, retrospective chart review conducted from July 2014 to June 2017 as a pre–post intervention study. The pre-intervention group included adult patients with HIV who received one or more doses of ART prior to implementation of the HIV medication restriction policy. The post-intervention group included adult patients with HIV who received one or more doses of ART after implementation of the policy. Exclusion criteria included patients who received ART for hepatitis B infection or prophylaxis, HIV post-exposure prophylaxis, or patients receiving a first dose of ART for occupational exposure. Home ART medication regimen and inpatient ART medication regimen were evaluated. The primary endpoint was to compare the rate of appropriate medication reconciliations completed before and after implementation of the HIV medication restriction policy. The secondary endpoint was to compare the time to restart of ART following admission. RESULTS: A total of 115 patients were included in this study. Appropriate medication reconciliation increased from 76% to 100% after implementation of the policy (P = 0.014). However, the mean time to re-initiation of ART increased from 7.9 hours to 14.5 hours after implementation of the policy (P = 0.01). ART regimens were restarted within 24 hours of admission in 96.7% of the pre-HIV policy group vs. 84% in the post-HIV policy group (P = 0.02). CONCLUSION: The mean time to re-initiation of ART increased after implementation of the HIV policy. However, restriction of ART ordering to infectious diseases physicians significantly increased the rate of appropriate medication reconciliation for patients with HIV. In light of these results, a procedure will be established to ensure the timely re-initiation of ART. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2018-11-26 /pmc/articles/PMC6253919/ http://dx.doi.org/10.1093/ofid/ofy210.596 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Barber, Elizabeth
Phe, Kady
Russo, Hannah Palmer
Mohajer, Mayar Al
589. Assessment of an Antiretroviral Therapy Policy in Patients with Human Immunodeficiency Virus at a Large Academic Medical Center
title 589. Assessment of an Antiretroviral Therapy Policy in Patients with Human Immunodeficiency Virus at a Large Academic Medical Center
title_full 589. Assessment of an Antiretroviral Therapy Policy in Patients with Human Immunodeficiency Virus at a Large Academic Medical Center
title_fullStr 589. Assessment of an Antiretroviral Therapy Policy in Patients with Human Immunodeficiency Virus at a Large Academic Medical Center
title_full_unstemmed 589. Assessment of an Antiretroviral Therapy Policy in Patients with Human Immunodeficiency Virus at a Large Academic Medical Center
title_short 589. Assessment of an Antiretroviral Therapy Policy in Patients with Human Immunodeficiency Virus at a Large Academic Medical Center
title_sort 589. assessment of an antiretroviral therapy policy in patients with human immunodeficiency virus at a large academic medical center
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253919/
http://dx.doi.org/10.1093/ofid/ofy210.596
work_keys_str_mv AT barberelizabeth 589assessmentofanantiretroviraltherapypolicyinpatientswithhumanimmunodeficiencyvirusatalargeacademicmedicalcenter
AT phekady 589assessmentofanantiretroviraltherapypolicyinpatientswithhumanimmunodeficiencyvirusatalargeacademicmedicalcenter
AT russohannahpalmer 589assessmentofanantiretroviraltherapypolicyinpatientswithhumanimmunodeficiencyvirusatalargeacademicmedicalcenter
AT mohajermayaral 589assessmentofanantiretroviraltherapypolicyinpatientswithhumanimmunodeficiencyvirusatalargeacademicmedicalcenter